eye problems with semaglutide Risk for a rare, potentially blinding condition was low, but it was significantly higher in diabetes patients who started (Ozempic) versus SGLT2 inhibitors, an observational study of U.S. veterans showed Study Finds No Statistical Link

John Barlow has sat on advisory board panels and received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mylan, Novartis and Sanofi/Aventis

doi: 10.1007/s11892-018-1099-9 7 Gonzaga-JaureguiCGeWStaplesJVan HoutCYadavAColonieRet al

Semaglutide is only FDA-approved for weight loss in injectable form, so we would consider weight loss from oral semaglutide to be a potential secondary benefit for overweight diabetics prescribed the drug

Most men notice less hair in the shower drain and on the pillow within 2 to 4 weeks

Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases

Sterling et al., 2021)